Indication
Myotonic Muscular Dystrophy
2 clinical trials
2 products
1 drug
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Phase 1/2 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple-Doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) PatientsStatus: Completed, Estimated PCD: 2023-02-14
Product
PlaceboProduct
AOC 1001Clinical trial
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous AOC 1001 for the Treatment of Myotonic Dystrophy Type 1Status: Not yet recruiting, Estimated PCD: 2026-10-01
Drug
Varlilumab